A detailed history of Washington Trust Advisors, Inc. transactions in Illumina, Inc. stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 5,623 shares of ILMN stock, worth $781,709. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,623
Previous 6,409 12.26%
Holding current value
$781,709
Previous $880,000 33.41%
% of portfolio
0.06%
Previous 0.08%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$101.05 - $133.57 $79,425 - $104,986
-786 Reduced 12.26%
5,623 $586,000
Q1 2024

May 07, 2024

SELL
$127.73 - $147.2 $57,733 - $66,534
-452 Reduced 6.59%
6,409 $880,000
Q4 2023

Jan 18, 2024

SELL
$92.79 - $142.53 $1.46 Million - $2.24 Million
-15,750 Reduced 69.66%
6,861 $955,000
Q3 2023

Oct 18, 2023

SELL
$128.91 - $192.44 $163,973 - $244,783
-1,272 Reduced 5.33%
22,611 $3.1 Million
Q2 2023

Jul 27, 2023

BUY
$183.43 - $232.67 $3,852 - $4,886
21 Added 0.09%
23,883 $4.48 Million
Q1 2023

May 04, 2023

SELL
$193.75 - $232.55 $33,131 - $39,766
-171 Reduced 0.71%
23,862 $5.55 Million
Q4 2022

Feb 08, 2023

SELL
$187.24 - $242.74 $192,108 - $249,051
-1,026 Reduced 4.09%
24,033 $4.86 Million
Q3 2022

Oct 14, 2022

SELL
$177.23 - $227.44 $30,660 - $39,347
-173 Reduced 0.69%
25,059 $4.78 Million
Q2 2022

Jul 25, 2022

BUY
$181.58 - $368.0 $641,158 - $1.3 Million
3,531 Added 16.27%
25,232 $4.65 Million
Q1 2022

May 05, 2022

BUY
$303.87 - $423.8 $296,577 - $413,628
976 Added 4.71%
21,701 $7.58 Million
Q4 2021

Feb 11, 2022

BUY
$347.28 - $421.83 $7.2 Million - $8.74 Million
20,725 New
20,725 $7.89 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.9B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Washington Trust Advisors, Inc. Portfolio

Follow Washington Trust Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust Advisors, Inc. with notifications on news.